TAIRNUMI Trademark

Trademark Overview


On Thursday, June 19, 2025, a trademark application was filed for TAIRNUMI with the United States Patent and Trademark Office. The USPTO has given the TAIRNUMI trademark a serial number of 99242263. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, January 8, 2026. This trademark is owned by CHIESI FARMACEUTICI S.P.A.. The TAIRNUMI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system diseases and disorders; Natural remedy preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system diseases and disorders; Medical plasters; Food supplements; Nutraceuticals for use as a dietary supplement; Vitamin preparations in the nature of food supplements; Dietetic preparations adapted for medical use; Dietary supplements consisting of vitamins
tairnumi

General Information


Serial Number99242263
Word MarkTAIRNUMI
Filing DateThursday, June 19, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, January 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 27, 2026

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system diseases and disorders; Natural remedy preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system diseases and disorders; Medical plasters; Food supplements; Nutraceuticals for use as a dietary supplement; Vitamin preparations in the nature of food supplements; Dietetic preparations adapted for medical use; Dietary supplements consisting of vitamins

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 19, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCHIESI FARMACEUTICI S.P.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressParma (PR) I-43122
IT

Trademark Events


Event DateEvent Description
Thursday, June 19, 2025NEW APPLICATION ENTERED
Thursday, June 19, 2025APPLICATION FILING RECEIPT MAILED
Friday, June 20, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 20, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 20, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 6, 2025ASSIGNED TO EXAMINER
Wednesday, November 12, 2025NON-FINAL ACTION WRITTEN
Wednesday, November 12, 2025NON-FINAL ACTION E-MAILED
Wednesday, November 12, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 22, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 5, 2026EXAMINERS AMENDMENT -WRITTEN
Monday, January 5, 2026EXAMINERS AMENDMENT E-MAILED
Monday, January 5, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 5, 2026EXAMINER'S AMENDMENT ENTERED
Monday, January 5, 2026APPROVED FOR PUB - PRINCIPAL REGISTER